EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cannabidiol- and Celecoxib-Loaded Liposomes as a Strategy to Modulate Redox and Inflammatory Signaling in High-Grade Glioma: A Preliminary In Vivo Study

Anna Rybarczyk iD, Aleksandra Majchrzak-Celińska iD, Ludwika Piwowarczyk, Szymon Tomczak iD, Dorota Wronka iD, Anna Karlik iD, Łukasz Przybył iD, Violetta Krajka-Kuźniak iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27146220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Anna Rybarczyk und 7 weiteren Autor:innen. Beteiligte Einrichtung: Poznan University of Medical Sciences, Department of Pharmaceutical Biochemistry, Rokietnicka 3, 60-806 Poznań, Poland. Hauptthemen laut MEDLINE: Celecoxib, Cannabidiol, Liposomes, Glioma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre, Polish National Science Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation contributes to the rapid progression of high-grade gliomas, indicating that anti-inflammatory strategies targeting NF-κB signaling may offer therapeutic benefit. Cannabidiol (CBD) and celecoxib (CELE) are hydrophobic pharmacological agents whose formulation in lipid carriers may support their combined biological evaluation. In this proof-of-concept study, we investigated liposomal formulations containing CBD, CELE, or both compounds in U-87 MG high-grade glioma cells and in a subcutaneous xenograft model. We assessed cytotoxicity, apoptosis, oxidative stress, Nrf2-dependent responses, NF-κB-centered inflammatory networks, tumor cell invasive properties, and Wnt/β-catenin pathway activity. The nanoformulations induced reactive oxygen species generation by 1.8-fold, which was accompanied by Nrf2 activation. Cationic formulations loaded with the compounds produced more pronounced pro-apoptotic effects (up to 39%) than POPC liposomes, although both types reduced the nuclear translocation of the NF-κB p65 subunit. The CBD + CELE-containing formulation showed a trend toward reduced tumor progression in mice. It is important to note that the in vitro and in vivo nanoformulations were physicochemically related, but not identical, and the in vivo experiment should be interpreted as a preliminary assessment after intratumoral administration. Overall, cationic liposomes co-loaded with CBD + CELE represent a promising platform for further optimization aimed at coordinated modulation of inflammatory, oxidative, and proliferative pathways in glioma. However, additional studies, including tissue distribution, release kinetics, and efficacy in orthotopic glioma models, are needed to fully verify their translational potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CelecoxibCannabidiolLiposomesGliomaInflammationBrain NeoplasmsAnimalsHumansMiceCell Line, TumorApoptosisOxidation-ReductionNF-kappa BSignal TransductionXenograft Model Antitumor AssaysOxidative StressReactive Oxygen SpeciesNF-E2-Related Factor 2

Stichwörter der Autor:innen

NF-κB pathwayNrf2 pathwayWnt/β-catenin pathwaycannabidiol (CBD)celecoxib (CELE)combinatorial treatmenthigh-grade gliomaliposomesmice xenograft modelnanoformulations

Substanzen

CelecoxibCannabidiolLiposomesNF-kappa BReactive Oxygen SpeciesNF-E2-Related Factor 2

Autor:innen und Institutionen

  • Poznan University of Medical Sciences, Department of Pharmaceutical Biochemistry, Rokietnicka 3, 60-806 Poznań, Poland.
  • Poznan University of Medical Sciences, Doctoral School, Bukowska 70, 60-812 Poznań, Poland.
  • Poznan University of Medical Sciences, Department of Pharmaceutical Chemistry, Rokietnicka 3, 60-806 Poznań, Poland.
  • Polish Academy of Sciences, Institute of Bioorganic Chemistry, Laboratory of Mammalian Model Organisms, Noskowskiego 12/14, 61-704 Poznań, Poland.

ORCID-Profile: Anna Rybarczyk, Aleksandra Majchrzak-Celińska, Szymon Tomczak, Dorota Wronka, Anna Karlik, Łukasz Przybył, Violetta Krajka-Kuźniak

Förderung

  • National Science Centre
  • Polish National Science Centre

Zitieren

APA

Rybarczyk, A., Majchrzak-Celińska, A., Piwowarczyk, L., Tomczak, S., Wronka, D., Karlik, A., Przybył, Ł., & Krajka-Kuźniak, V. (2026). Cannabidiol- and Celecoxib-Loaded Liposomes as a Strategy to Modulate Redox and Inflammatory Signaling in High-Grade Glioma: A Preliminary In Vivo Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27146220

Vancouver

Rybarczyk A, Majchrzak-Celińska A, Piwowarczyk L, Tomczak S, Wronka D, Karlik A, et al. Cannabidiol- and Celecoxib-Loaded Liposomes as a Strategy to Modulate Redox and Inflammatory Signaling in High-Grade Glioma: A Preliminary In Vivo Study. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27146220

BibTeX
@article{Rybarczyk2026,
  author = {Rybarczyk, Anna and Majchrzak-Celińska, Aleksandra and Piwowarczyk, Ludwika and Tomczak, Szymon and Wronka, Dorota and Karlik, Anna and Przybył, Łukasz and Krajka-Kuźniak, Violetta},
  title = {Cannabidiol- and Celecoxib-Loaded Liposomes as a Strategy to Modulate Redox and Inflammatory Signaling in High-Grade Glioma: A Preliminary In Vivo Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27146220}
}
Kostenlos starten →